Efficacy Evaluation of Bevacizumab Combined with Capecitabine in the Treatment of HER2-Negative Metastatic Breast Cancer: A Meta-Analysis

Figure 3

Forest chart and subgroup analysis of bevacizumab combined with capecitabine for PFS results.